THIS WEBSITE IS ON SALE!!
This repository of information on pharma regulatory affairs in Latin America could be yours. GET THE READER FLOW YOU NEED TO PROMOTE YOUR PHARMA CONSULTING BUSINESS!! 1,500 VISITORS A MONTH AND GROWING. GET IN TOUCH! inesitag@hotmail.com / maria@latampharmara.com
Our friends:
Index
- Regulatory Affairs in Emerging Markets
- Fundamentals of Regulatory Affairs
- Argentina
- Colombia
- Mexico
- Central America
- Interesting
- Blog
- Get in touch!
Category Archives: USA
Movies for regulatory professionals: Dallas Buyers Club (2013)
This is a movie I found especially interesting and enjoyable as a regulatory affairs professional, both because of the historical perspective, and because of the ethical and philosophical exercise of thought it brings. Dallas Buyers Club is a 2013 American biographical … Continue reading
Posted in Mexico, RA in Popular Culture, USA
Tagged AIDS, clinical trials, ethics, FDA, movie, popular culture, regulatory affairs
1 Comment
Americas Health Authorities Meeting
On the 20th and 21st of February of 2014, representatives of the five Latin-American Health Authorities of Regional Reference recognized by the Pan American Health Organization, plus those of the FDA, Health Canada, and El Salvador’s regulatory agency met in … Continue reading
Posted in Argentina, Brazil, Canada, Colombia, Cuba, Mexico, Uncategorized, USA
Tagged ANMAT, anvisa, Argentina, brazil, Canada, CECMED, COFEPRIS, Colombia, Cooperation, Cuba, drug products, FDA, health authority, Health Canada, Latin America, Mexican Health Agency, Mexico, Mikel Arriola, National Regulatory Agency of Regional Reference, PAHO, Pan American Health Authorization, regulatory affairs
2 Comments
List of FDA Advisory Committees
The FDA Advisory Committees for drugs and other healthcare products receive requests for technical and clinical evaluation of new drugs by the U.S. Food and Drug Administration. The committees, consisting of members from academic and clinical settings, the general public, … Continue reading
Posted in USA
Tagged Advisory Committee, drug products, FDA, regulatory affairs, USA
Leave a comment
